Clinical trial

Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated…

NCT00393679 · Institute of Tropical Medicine, Belgium, Other · Completed

Key facts

NCT number NCT00393679
Title Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children
Official title Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children
Lead sponsor Institute of Tropical Medicine, Belgium, Other
Collaborators Liverpool School of Tropical Medicine East African Network for Monitoring Antimalarial Treatment Centre Muraz University of Calabar Tropical Diseases Research Centre, Zambia University Hospital…
Status Completed
Phase Phase 3
Study type Interventional
Conditions Fever, Malaria
Intervention type Drug
Interventions amodiaquine-artesunate (ASAQ), dihydroartemisinin-piperaquine (DHAPQ), artemether-lumefantrine (AL), Lapdap (Chlorproguanil-Dapsone) + artesunate (AS)
Enrollment 4,112
Start date Jul 1, 2007
Primary completion Dec 1, 2009
Completion Dec 1, 2009
First posted Oct 30, 2006
Last update posted Feb 3, 2014
Countries Burkina Faso, Gabon, Mozambique, Nigeria, Rwanda, Uganda, Zambia

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies